Home » Cancer » Gynecologic Oncology » Multidisciplinary Approach to Cancer
Multidisciplinary Approach to Cancer
Methodist’s multidisciplinary approach to cancer.
What it is. Why it matters so much.
If you’re facing a gynecologic cancer, you want answers and action. You want medical experts with the greatest skill and experience to focus their knowledge on you and your best chance to beat this.
At Methodist, that’s exactly what we do.
Each week, we bring medical specialists from the areas or disciplines related to gynecologic cancer care into one room for a high-tech, high-energy treatment planning conference. This multidisciplinary team will review your symptoms and medical history, see your test results, suggest and analyze your options.
The discussion and debate is focused and purposeful: What combination of surgical or non-surgical treatments, including chemotherapy and radiation therapy, can offer the best possible outcome? What is the most tissue-sparing approach? Which clinical research trials should be considered? How can we work together to expedite care and ease the journey forward? How can our support services help?
The experts around the table include medical oncologists, surgical oncologists, radiation oncologists, interventional radiologists, pathologists, pharmacists, a psycho-oncologist, nurse coordinators, clinical research nurse, data manager, registered dietitian, social workers and others. Together, they will focus their decades of experience on mapping out a personalized care plan for your consideration.
After the conference, communication and collaboration remain paramount as we work with you and your personal physicians. Appointments and procedures are scheduled quickly and grouped as conveniently as possible.
And at every step along your journey, this team stands ready to review your progress and recommend adjustments to your care plan, if needed.
Multidisciplinary Cancer Treatment Planning Conferences
Methodist Estabrook Cancer Center brings together multidisciplinary teams of specialists for an interactive, in-depth weekly collaboration to develop the best possible treatment plan for individual cases of:
• Breast cancer
• Gynecologic cancer
• Lung cancer
• Gastrointestinal cancer
• Genitourinary cancer
• Head and neck cancer
• Neurological cancer
• Blood cancer (including leukemia, lymphoma, myeloma).